Jazz Pharmaceuticals (JAZZ) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Q3 2025 value amounting to -$48.6 million.
- Jazz Pharmaceuticals' Interest & Investment Income rose 1724.98% to -$48.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$205.9 million, marking a year-over-year increase of 1993.58%. This contributed to the annual value of -$238.1 million for FY2024, which is 1773.82% up from last year.
- Per Jazz Pharmaceuticals' latest filing, its Interest & Investment Income stood at -$48.6 million for Q3 2025, which was up 1724.98% from -$47.4 million recorded in Q2 2025.
- In the past 5 years, Jazz Pharmaceuticals' Interest & Investment Income ranged from a high of -$27.4 million in Q1 2021 and a low of -$93.4 million during Q3 2021
- Moreover, its 5-year median value for Interest & Investment Income was -$69.9 million (2021), whereas its average is -$66.1 million.
- Its Interest & Investment Income has fluctuated over the past 5 years, first tumbled by 24042.58% in 2021, then skyrocketed by 2711.45% in 2024.
- Quarter analysis of 5 years shows Jazz Pharmaceuticals' Interest & Investment Income stood at -$88.6 million in 2021, then increased by 16.34% to -$74.1 million in 2022, then grew by 5.13% to -$70.3 million in 2023, then increased by 27.11% to -$51.3 million in 2024, then grew by 5.23% to -$48.6 million in 2025.
- Its Interest & Investment Income stands at -$48.6 million for Q3 2025, versus -$47.4 million for Q2 2025 and -$51.3 million for Q4 2024.